We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
10 Year Est. Return
AUM
$417B
AUM Growth
-$1.66B
Cap. Flow
+$1.91B
Cap. Flow %
0.46%
Top 10 Hldgs %
9.45%
Holding
4,011
New
140
Increased
1,618
Reduced
1,966
Closed
139

Sector Composition

Rank Sector Weight
1 Healthcare 15.1%
2 Financials 12.85%
3 Technology 12.68%
4 Industrials 10.63%
5 Consumer Discretionary 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSMT icon
1626
Pricesmart
PSMT
$5.94B
$42.8M 0.01%
468,802
-10,989
-2% -$921K
CHCO icon
1627
City Holding Co
CHCO
$2.05B
$42.7M 0.01%
866,584
-26,816
-3% -$1.26M
TVTX icon
1628
Travere Therapeutics
TVTX
$5.17B
$42.7M 0.01%
1,287,202
+195,218
+18% +$5.35M
KRA
1629
DELISTED
Kraton Corporation
KRA
$42.6M 0.01%
1,785,604
-77,065
-4% -$1.74M
NXST icon
1630
Nexstar Media Group
NXST
$6.01B
$42.5M 0.01%
759,753
-34,094
-4% -$1.95M
SGY
1631
DELISTED
Stone Energy
SGY
$42.3M 0.01%
59,174
-1,128
-2% -$959K
WD icon
1632
Walker & Dunlop
WD
$1.73B
$42.3M 0.01%
1,581,633
+1,110,881
+236% +$24.7M
TMP icon
1633
Tompkins Financial
TMP
$1.42B
$42.2M 0.01%
785,823
-11,012
-1% -$582K
BCRX icon
1634
BioCryst Pharmaceuticals
BCRX
$2.42B
$42.2M 0.01%
2,823,718
-37,182
-1% -$423K
SUPN icon
1635
Supernus Pharmaceuticals
SUPN
$2.7B
$42.2M 0.01%
2,482,690
+1,125,874
+83% +$16M
BBD icon
1636
Banco Bradesco
BBD
$37.4B
$42.1M 0.01%
9,776,393
+179,647
+2% +$827K
SBH icon
1637
Sally Beauty Holdings
SBH
$1.47B
$42.1M 0.01%
1,333,196
+17,164
+1% +$545K
EIG icon
1638
Employers Holdings
EIG
$907M
$42M 0.01%
1,844,467
-679
-0% -$16.6K
IVC
1639
DELISTED
Invacare Corporation
IVC
$42M 0.01%
1,942,453
-12,520
-0.6% -$265K
CVCO icon
1640
Cavco Industries
CVCO
$4.36B
$41.8M 0.01%
554,688
-31,947
-5% -$2.29M
N
1641
DELISTED
Netsuite Inc
N
$41.8M 0.01%
455,846
+858
+0.2% +$81.3K
CBI
1642
DELISTED
Chicago Bridge & Iron Nv
CBI
$41.8M 0.01%
835,182
+14,039
+2% +$730K
SBSI icon
1643
Southside Bancshares
SBSI
$963M
$41.8M 0.01%
1,538,379
-18,942
-1% -$489K
CDW icon
1644
CDW
CDW
$18.9B
$41.8M 0.01%
1,218,281
+402,497
+49% +$15M
ACET
1645
DELISTED
Aceto Corp
ACET
$41.7M 0.01%
1,695,059
+343
+0% +$7.72K
TMHC
1646
DELISTED
Taylor Morrison
TMHC
$41.7M 0.01%
2,046,717
+436,975
+27% +$8.65M
BH icon
1647
Biglari Holdings Class B
BH
$1.2B
$41.6M 0.01%
150,905
-4,636
-3% -$1.21M
CSH
1648
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
$41.5M 0.01%
1,584,148
-134,046
-8% -$3.56M
ARNA
1649
DELISTED
Arena Pharmaceuticals Inc
ARNA
$41.5M 0.01%
893,352
-24,312
-3% -$1.05M
CFNL
1650
DELISTED
Cardinal Financial Corp
CFNL
$41.4M 0.01%
1,901,854
-22,713
-1% -$473K

Similar funds

BlackRock Fund Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, BlackRock Fund Advisors held 4,011 positions worth $417B, down 0.4% from $419B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

BlackRock Fund Advisors's Q2 2015 filing shows 140 new, 1,618 increased, 1,966 reduced and 139 closed positions. Its largest new stake was Jazz Pharmaceuticals: 1,516,810 shares worth $267M. The largest sale was LORILLARD INC COM STK, an estimated $553M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • BlackRock Fund Advisors's largest Q2 2015 buy was Jazz Pharmaceuticals: 1,516,810 shares worth $267M.
  • BlackRock Fund Advisors added most to iShares MSCI Germany ETF in Q2 2015, an estimated $739M increase.
  • BlackRock Fund Advisors's biggest Q2 2015 reduction was Qorvo, cutting an estimated $377M.
  • BlackRock Fund Advisors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $553M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.5% of its $417B portfolio in Q2 2015.
  • BlackRock Fund Advisors opened 140 new positions and closed 139 in Q2 2015.
  • BlackRock Fund Advisors's portfolio value fell 0.4% quarter-over-quarter to $417B.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.